Home › Glioblastoma › Illinois › Chicago
Pag-aaral pangklinika para sa Glioblastoma sa Chicago, IL
Isang pag-aaral para sa Glioblastoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Chicago. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
Nagre-recruitPhase 3
- Northwestern University, Chicago
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
Nagre-recruitPhase 1/2
- University of Chicago Comprehensive Cancer Center, Chicago
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
Nagre-recruitPhase 1
- Northwestern Univerity, Chicago
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Nagre-recruitPhase 1/2
- Northwestern Memorial Hospital, Chicago
Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma
Nagre-recruitPhase 1
- Northwestern University, Chicago
Targeted Pediatric High-Grade Glioma Therapy
Nagre-recruitObservasyonal na pag-aaral
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
Nagre-recruitPhase 1
- Northwestern University, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Study of Olutasidenib and Temozolomide in HGG
Nagre-recruitPhase 2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Nagre-recruitPhase 3
- University of Chicago, Chicago
A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
Nagre-recruitPhase 1
- Northwestern Medicine, Chicago
WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Nagre-recruitPhase 2
- Northwestern University, Chicago
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Nagre-recruitPhase 2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Nagre-recruitPhase 1/2
- Northwestern Memorial Hospital, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Chicago
Pag-aaral para sa Glioblastoma sa ibang lungsod
- New York City, NY30 pag-aaral
- Boston, MA28 pag-aaral
- Houston, TX26 pag-aaral
- Los Angeles, CA24 pag-aaral
- Durham, NC20 pag-aaral
- San Francisco, CA17 pag-aaral
- Washington, DC15 pag-aaral
- Columbus, OH14 pag-aaral
- Miami, FL14 pag-aaral
- Rochester, MN13 pag-aaral
- Jacksonville, FL13 pag-aaral
- Aurora, CO12 pag-aaral
Iba pang pag-aaral sa Chicago
- Non-Small Cell Lung Cancer61 pag-aaral
- Kanser sa Suso59 pag-aaral
- Kanser (lahat ng uri)51 pag-aaral
- Metastatic Cancer45 pag-aaral
- Kanser sa Prostate45 pag-aaral
- Kanser sa Baga41 pag-aaral
- Obesity41 pag-aaral
- Kanser sa Ovary36 pag-aaral
- Colorectal Cancer34 pag-aaral
- Stroke34 pag-aaral
- Pagkabigo ng Puso31 pag-aaral
- Overweight29 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.